Exact Mass: 434.2347

A diterpenoid isolated from Ajuga bracteosa.

Phorbol 13-butanoate

Oleoylglycerone phosphate

1-oleoyl-2-lyso-glycerone phosphate

Glutathionylspermidine

N1-(γ-L-Glutamyl-L-cysteinyl-glycyl)-spermidine

The spermidine amide of glutathione.

Ajugarin I

Quassin

Nigakilactone C; Quassin

Lexibulin

CYT997(Lexibulin)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent

LysoPA(0:0/18:2(9Z,12Z))

{3-hydroxy-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy}phosphonic acid

LysoPA(0:0/18:2(9Z,12Z)) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293).

LysoPA(18:2(9Z,12Z)/0:0)

{2-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy}phosphonic acid

LPA(18:2(9Z,12Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293) [HMDB] LysoPA(18:2(9Z,12Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293).

(2s)-2-[[(2s)-2-Acetamido-5-[[n-(Methylcarbamoyl)carbamimidoyl]amino]pentanoyl]-Methyl-Amino]-3-Phenyl-Propanoic Acid

2-{2-[(1-hydroxyethylidene)amino]-N-methyl-5-({[(methyl-C-hydroxycarbonimidoyl)amino]methanimidoyl}amino)pentanamido}-3-phenylpropanoate

Lexibulin

1-ethyl-3-[2-methoxy-4-[5-methyl-4-[[(1S)-1-pyridin-3-ylbutyl]amino]pyrimidin-2-yl]phenyl]urea

Lophanthoidin F

2-(10-Ethoxy-1,9-dihydroxy-4b,8,8-trimethyl-3,4-dioxo-5,6,7,8a,9,10-hexahydrophenanthren-2-yl)propyl acetate

6-[(3E,6E)-2,5-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-3,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one

omriolide B

3-acetyleriocasin C|3beta,19-diacetoxy-6beta-hydroxy-7,16-dioxo-ent-abieta-15(17)-ene

inflexarabdonin B

3beta,19-diacetoxy-7alpha,14beta-dihydroxy-ent-kaur-16-en-15-one|pharicinin C

Rastronol A

3alpha-hydroxy-2alpha-succinyloxy-labda-3,13-dien-15,16-olide

1alpha-Hydroxy-6-O-isobutyryl-3beta-(2-methylbutyryloxy)steiractinolid

taibairubescensin C

17-hydroxy-7beta-succinyloxy-ent-cleroda-3,13-dien-15,16-olide

C24H34O7

norrlandin

sarcophytolin A

pachyclavulariolide G

aplyviolacene|macfarlandin E

1alpha-tigloyloxypolyachyrol

2alpha,10alpha-diacetoxy-7,8,18,19-diepoxydolabell-3(E)-en-14-one

Shahamin I

6alpha,17alpha-dihydroxy-15,17-oxidospongian-16-one 6,17-diacetate

verrucosidinol

12-beta-Acetoxy-Dendrillolide A

6,7-dihydroxykaratavicinol

1alpha-senecioyloxypolyachyrol

NSC365730

(1R,4S,4aR.6S)-6-acetoxy-4-((5R)-5-acetoxy-1-methylenehexyl)-1-(3-methylbut-2-enyl)-4,4a,5,6-tetrahydro-1H,3H-pyrano[3,4-c]pyran-3-one|(1R,4S,4aR.6S)-6-acetoxy-4-<(5R)-5-acetoxy-1-methylenehexyl>-1-(3-methylbut-2-enyl)-4,4a,5,6-tetrahydro-1H,3H-pyrano<3,4-c>pyran-3-one

(1R*,4S*,4aR*.6S*)-6-acetoxy-4-((5R)-5-acetoxy-1-methylenehexyl)-1-(3-methylbut-2-enyl)-4,4a,5,6-tetrahydro-1H,3H-pyrano[3,4-c]pyran-3-one|(1R*,4S*,4aR*.6S*)-6-acetoxy-4-<(5R)-5-acetoxy-1-methylenehexyl>-1-(3-methylbut-2-enyl)-4,4a,5,6-tetrahydro-1H,3H-pyrano<3,4-c>pyran-3-one

heteroscypholide A|Jeterpscypholide A

Exsertifolin D

8-epi-uprolide-B diacetate|uprolide-B diacetate

7-epi-uprolide-C diacetate|Di-Ac-(1S,3R,4R,7S,12S,13R,14R)-3,4-Epoxy-7,13-dihyroxy-8(19),15(17)-cembradien-16,14-olide

macfarlandin E

astrogorgin J

caesall G

sarcocrassocolide P

14alpha,17-diacetoxymulin-12-ene-11-one-20-oic acid|mulinone a

12alpha,14beta-dihydroxy-7alpha,18-diacetoxy-ent-kaur-16-en-15-one|wikstroemioidin G

11alpha,17-diacetoxymulin-12-en-14-one-20-oic acid|mulinone b

scapanialide B

pseurata H

6,19-Di-Ac-2,6,19-Trihydroxy-8,13-labdadien-15,16-olide

1,1-trisulfanediyl-bis-undecan-3-one

C22H42O2S3 (434.2347)

thuridillin-C

Leucophyllin E

7beta,11beta-diacetoxy-16-oxospongian-17-al

Lushanrubescensin E

rhabdastin C

Maoecrystal F

3beta,11beta-diacetoxy-2beta,6alpha-dihydroxy-ent-kaur-16-en-15-one|taibairubescensin B

11alpha,19-Dihydroxytelocinobufagin

19-acetoxypregaleopsin

3beta,11beta-dihydroxy-6alpha,7beta-diacetoxy-ent-kaur-16-en-15-one|xindongnin C

Rosthornin B

[(1R,4R,5R,9R,10R,13R)-11-acetyloxy-2,13-dihydroxy-5,9-dimethyl-14-methylidene-15-oxo-5-tetracyclo[11.2.1.01,10.04,9]hexadecanyl]methyl acetate

6beta,19-diacetoxy-1alpha,15beta-dihydroxy-ent-kaur-16-en-7-one|maoesin E

ACMC-20lx50

Pro Arg Tyr

prolyltyrosylarginine

tyrosylprolylarginine

6-[(4E,6E)-2,3-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-4,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one

NCGC00380375-01!6-[(4E,6E)-2,3-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-4,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one

C24H34O7_{(1R,4aR,5S,6R,8S,8aR)-8-Acetoxy-5,6-dimethyl-5-[(2S,3aS,6aS)-2,3,3a,6a-tetrahydrofuro[2,3-b]furan-2-yl]octahydro-8aH-spiro[naphthalene-1,2-oxiran]-8a-yl}methyl acetate

NCGC00347625-02_C24H34O7_{(1R,4aR,5S,6R,8S,8aR)-8-Acetoxy-5,6-dimethyl-5-[(2S,3aS,6aS)-2,3,3a,6a-tetrahydrofuro[2,3-b]furan-2-yl]octahydro-8aH-spiro[naphthalene-1,2-oxiran]-8a-yl}methyl acetate

3-Deoxycaryoptinol

6-[(4E,6E)-2,3-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-4,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one [IIN-based: Match]

NCGC00380375-01!6-[(4E,6E)-2,3-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-4,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one [IIN-based: Match]

6-[(4E,6E)-2,3-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-4,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one [IIN-based on: CCMSLIB00000847678]

NCGC00380375-01!6-[(4E,6E)-2,3-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-4,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one [IIN-based on: CCMSLIB00000847678]

6-[(4E,6E)-2,3-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-4,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one [IIN-based on: CCMSLIB00000847677]

NCGC00380375-01!6-[(4E,6E)-2,3-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-4,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one [IIN-based on: CCMSLIB00000847677]

Cys Gly Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}hexanamido]hexanoic acid

Cys Lys Gly Lys

(2S)-6-amino-2-{2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]acetamido}hexanoic acid

Cys Lys Lys Gly

2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]hexanamido]acetic acid

Gly Cys Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]hexanamido]hexanoic acid

Gly Lys Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-sulfanylpropanamido]hexanoic acid

Gly Lys Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]hexanamido]-3-sulfanylpropanoic acid

Ile Thr Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

Lys Cys Gly Lys

(2S)-6-amino-2-{2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]acetamido}hexanoic acid

Lys Cys Lys Gly

2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]hexanamido]acetic acid

Lys Gly Cys Lys

(2S)-6-amino-2-[(2R)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-sulfanylpropanamido]hexanoic acid

Lys Gly Lys Cys

(2R)-2-[(2S)-6-amino-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}hexanamido]-3-sulfanylpropanoic acid

Lys Lys Cys Gly

2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-sulfanylpropanamido]acetic acid

Lys Lys Gly Cys

(2R)-2-{2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]acetamido}-3-sulfanylpropanoic acid

Arg Pro Tyr

Leu Thr Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

Tyr Arg Pro

Pro Tyr Arg

Arg Tyr Pro

Thr Ile Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

Tyr Pro Arg

Thr Leu Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

Thr Thr Ile Thr

(2S,3R)-2-[(2S,3S)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-methylpentanamido]-3-hydroxybutanoic acid

Thr Thr Leu Thr

(2S,3R)-2-[(2S)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-4-methylpentanamido]-3-hydroxybutanoic acid

Thr Thr Thr Ile

(2S,3S)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-3-methylpentanoic acid

Thr Thr Thr Leu

(2S)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-4-methylpentanoic acid

LPA(18:2)

1-(9Z,12Z-Octadecadienoyl)-phosphatidic acid

PA(18:2(9Z,12Z)/0:0)

1-(9Z,12Z-octadecadienoyl)-glycero-3-phosphate

LPA 18:2

2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphate

ST 24:4;O7

1beta,3beta,5beta,14beta,16beta-pentahydroxy-bufa-20,22-dienolide

(R)-1-BOC-4-(3-CBZ-AMINO-3-METHOXYCARBONYL-PROPYL)PIPERIDINE

C23H34N2O6 (434.2417)

1-N,4-N-bis(2-methylphenyl)-3,6-dipropyl-1,2,4,5-tetrazine-1,4-dicarboxamide

butyl 2-methylprop-2-enoate,4-hydroxy-2-methylidenebutanoic acid,prop-2-enoic acid,styrene

5-CHLORO-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-(TRIISOPROPYLSILYL)-1H-PYRROLO[2,3-B]PYRIDINE

C22H36BClN2O2Si (434.2327)

sodium 2-[2-[2-(tridecyloxy)ethoxy]ethoxy]ethyl sulphate

C19H39NaO7S (434.2314)

zinc bis(isoundecanoate)

C22H42O4Zn (434.2374)

4-CHLORO-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-(TRIISOPROPYLSILYL)-1H-PYRROLO[2,3-B]PYRIDINE

C22H36BClN2O2Si (434.2327)

Acrylic acid, butyl acrylate, 2-hydroxyethyl methacrylate, styrene polymer

1-N,4-N-bis(3-methylphenyl)-3,6-dipropyl-1,2,4,5-tetrazine-1,4-dicarboxamide

(2-(7-(2-(4-Cyano-2-fluorophenoxy)ethyl)-9-oxa-3,7-diazabicyclo(3.3.1)non-3-yl)ethyl)carbamic acid tert-butyl ester

C22H31FN4O4 (434.2329)

Tyrosyl-prolyl-arginine

LPA(0:0/18:2(9Z,12Z))

1-Oleoyl-sn-glycero-3-phosphate(2-)

(Z)-octadec-11-enoylglycerol 3-phosphate

a 1-Octadec-11-enoyl-sn-glycerol 3-phosphate

(2S)-2-amino-5-[[(2R)-1-[[2-[4-(3-aminopropylamino)butylamino]-2-oxoethyl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid

Ac-DL-Arg(CONHMe)-DL-N(Me)Phe-OH

3-acetyleriocasin C, (rel)-

A natural product found in Isodon eriocalyx.

Maoesin E, (rel)-

A natural product found in Isodon eriocalyx.

N-[2-(tert-butylamino)-2-oxo-1-(3-pyridinyl)ethyl]-N-(4-tert-butylphenyl)-5-oxazolecarboxamide

N-[2-(cyclopentylamino)-2-oxoethyl]-4,7-dimethyl-N-(2-methylphenyl)-2-oxo-3H-pyrido[1,2-a]pyrimidine-4-carboxamide

2-Oleoyl-sn-glycero-3-phosphate(2-)

2-Oxo-3-(stearoyloxy)propyl phosphate

(2E,4E,8S,10E,12Z)-1-[(3E,5S)-5-[(4-hydroxyphenyl)methyl]-2,4-dioxopyrrolidin-3-ylidene]-4,8-dimethyltetradeca-2,4,10,12-tetraen-1-olate

C27H32NO4- (434.2331)

Arg-Pro-Tyr

Pro-Arg-Tyr

(6S,7S,8S)-N-cyclohexyl-8-(hydroxymethyl)-2-oxo-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7R,8R)-N-cyclohexyl-8-(hydroxymethyl)-2-oxo-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-(3-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone

[(1R)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-(3-pyridinyl)methanone

1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-(2-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone

(6S,7S,8R)-N-cyclohexyl-8-(hydroxymethyl)-2-oxo-7-(4-pyridin-4-ylphenyl)-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

1-[(1S)-1-(hydroxymethyl)-7-methoxy-2-(3-pyridinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-1-butanone

[(1S)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-(3-pyridinyl)methanone

Arg-Tyr-Pro

Pro-Tyr-Arg

Tyr-Arg-Pro

6-[(4E,6E)-2,3-dihydroxy-4,6-dimethyl-7-(2,4,5-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-2-yl)hepta-4,6-dien-2-yl]-4-methoxy-3,5-dimethylpyran-2-one

Nigakilactone C

1-Oleoylglycerone 3-phosphate

A 1-acylglycerone 3-phosphate in which the acyl group is specified as oleoyl.

LysoPA(18:2(9Z,12Z)/0:0)

2-Linoleoyl-glycero-3-phosphate

1-(9Z,12Z-octadecadienoyl)-glycero-3-phosphate

lysophosphatidic acid 0:0/18:2(9Z,12Z)

A 2-acyl-sn-glycerol 3-phosphate having (9Z,12Z)-octadeca-9,12-dienoyl as the 2-O-acyl group.

1-linoleoyl-sn-glycerol 3-phosphate

A 1-acyl-sn-glycerol 3-phosphate having linoleyl (9Z,12Z-octadecadienoyl) as the 1-O-acyl group.

1-Oleoyl-sn-glycero-3-phosphate(2-)

A 1-acyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-oleoyl-sn-glycero-3-phosphate.

1-stearoylglycerone 3-phosphate(2-)

A 1-acylglycerone 3-phosphate(2-) obtained by deprotonation of the phospho groups of 1-stearoylglycerone 3-phosphate; major species at pH 7.3.

2-Oleoyl-sn-glycero-3-phosphate(2-)

A 2-acyl-sn-glycero-3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 2-oleoyl-sn-glycero-3-phosphate; major species at pH 7.3.

LPA 18:2/0:0

PA O-14:1/4:1

PA O-16:2/2:0

PA O-18:2

PA P-14:0/4:1

PA P-14:0/4:1 or PA O-14:1/4:1

PA P-16:1/2:0

PA P-16:1/2:0 or PA O-16:2/2:0

PA P-18:1

PA P-18:1 or PA O-18:2

LPEth 16:2

LPM 17:2

Tyr-Pro-Arg

ST 18:2;O;GlcA

ST 18:3;O2;Hex

(1s,4as,5r,6s,8r,8as)-5-[(2r,3ar,6ar)-2h,3h,3ah,6ah-furo[2,3-b]furan-2-yl]-8-(acetyloxy)-5,6-dimethyl-hexahydro-2h-spiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate

(1s,3r,4s,6r,7s,9r,10s,11s,13s)-6-(acetyloxy)-3,7-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate

(2r,3r,4s,6s,9s,10s,11s,13s)-6-(acetyloxy)-2,11-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate

(2r)-3-hydroxy-2-[(9z,12z)-octadeca-9,12-dienoyloxy]propoxyphosphonic acid

(1r,2r,3r,4s,6s,9s,10s,11s,13s)-2-(acetyloxy)-6,11-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate

(1s,3s,4r,7s,8r,9s,10s,12r,14s,15r)-7-(acetyloxy)-3-hydroxy-5,5,9,15-tetramethyl-16-oxo-11-oxapentacyclo[12.2.1.0¹,¹⁰.0⁴,⁹.0¹⁰,¹²]heptadecan-8-yl acetate

7-{[(2e,6s,7r,10r)-6,7,10,11-tetrahydroxy-3,7,11-trimethyldodec-2-en-1-yl]oxy}chromen-2-one

(1r,2s,5s,7r,9s,10s,11r,18r)-10-(acetyloxy)-9,18-dihydroxy-12,12-dimethyl-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-7-yl acetate

14-(hydroxymethyl)-3,10,12,16-tetramethyl-15,17-dioxo-18,20-dioxatetracyclo[11.5.2.0¹,⁶.0¹⁶,¹⁹]icos-4-ene-4-carboxylic acid

1-(acetyloxy)-4a,7-dihydroxy-4,4,7,11b-tetramethyl-1h,2h,3h,5h,6h,6ah,11h,11ah-phenanthro[3,2-b]furan-6-yl acetate

8-[1-(4,4,7a-trimethyl-hexahydro-1h-inden-1-yl)ethenyl]-4-(acetyloxy)-3-oxo-2,7-dioxabicyclo[3.2.1]octan-6-yl acetate

(2r,3r,5s,8r,9r,10r)-9-(acetyloxy)-2,5-dihydroxy-8,12,15,15-tetramethyl-4-methylidene-13-oxotricyclo[9.3.1.0³,⁸]pentadec-11-en-10-yl acetate

(1s,4s,6r,7s,10s,11s,13s)-6-(acetyloxy)-3,7-dihydroxy-5,5,9-trimethyl-14-methylidene-15-oxotetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate

(3ar,5s,6r,15s,15ar)-5-(acetyloxy)-6-hydroxy-6,10,14-trimethyl-3-methylidene-2-oxo-3ah,4h,5h,7h,8h,11h,12h,15h,15ah-cyclotetradeca[b]furan-15-yl acetate

(1r,2r,3r,5s,8r,9r,10r)-9-(acetyloxy)-2,5-dihydroxy-8,12,15,15-tetramethyl-4-methylidene-13-oxotricyclo[9.3.1.0³,⁸]pentadec-11-en-10-yl acetate

(3ar,3br,4s,5as,9as,9br,10s,11ar)-4-(acetyloxy)-3b-formyl-6,6,9a-trimethyl-1-oxo-dodecahydrophenanthro[1,2-c]furan-10-yl acetate

4-(acetyloxy)-3-oxo-8-(1,4,4-trimethyl-8-methylidene-hexahydro-2h-azulen-1-yl)-2,7-dioxabicyclo[3.2.1]octan-6-yl acetate

6beta-hydroxy-7-alpha-ethoxy-16-acetoxyroyleanone

{"Ingredient_id": "HBIN012272","Ingredient_name": "6beta-hydroxy-7-alpha-ethoxy-16-acetoxyroyleanone","Alias": "NA","Ingredient_formula": "C24H34O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31191","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

adenanthin f

{"Ingredient_id": "HBIN014677","Ingredient_name": "adenanthin f","Alias": "NA","Ingredient_formula": "C24H34O7","Ingredient_Smile": "CC(=O)OC1CC2C(C(CC(C2(C3C14CC(CC3O)C(=C)C4=O)C)O)OC(=O)C)(C)C","Ingredient_weight": "434.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "610","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10873754","DrugBank_id": "NA"}

adenanthin g